全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Considerations and Experience in the Treatment of Lung Cancer with VMAT SBRT + DIBH in Arms-Down Position

DOI: 10.4236/ijmpcero.2021.102007, PP. 69-80

Keywords: Lung Cancer, VMAT, SBRT, DIBH, Arms-Down Position

Full-Text   Cite this paper   Add to My Lib

Abstract:

The arms-up position is the most common treatment position adopted for lung cancer patients treated with radiation therapy. However, many elderly or frail patients have shoulder problems and cannot tolerate such an overstretched position for an extended period. Therefore, the arms-down position becomes the only alternative for this group of patients during radiation therapy. Even though the arms-down position is not ideal, it does provide a stable and comfortable patient immobilization position for radiation treatments that require a longer delivery time, such as stereotactic body radiation therapy (SBRT). In this study, we designed a protocol to treat lung cancer patients with VMAT stereotactic body radiation therapy (VMAT SBRT) and deep inspiration breath-hold (DIBH) in the arms-down position. Our initial clinical experience with this protocol indicates that it is reliable for patient immobilization and accurate in delivered dosimetry.

References

[1]  Surveillance, Epidemiology, and End Results Program (SEER), National Cancer Institute. (2021) Cancer Statistics Facts: Lung and Bronchus Cancer.
https://seer.cancer.gov/statfacts/html/lungb.html
[2]  NCCN Clinical Practice Guidelines in Oncology. (2018) National Comprehensive Cancer Network (NCCN). Version 3, February 21, 2018.
https://www.nccn.org
[3]  Mok, T.S., Wu, Y.L., Ahn, M.J., Garassino, M.C., Kim, H.R., et al. (2017) Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. The New England Journal of Medicine, 376, 629-640.
https://doi.org/10.1056/NEJMoa1612674
http://www.nejm.org/doi/full/10.1056/NEJMoa1612674
[4]  Soria, J.C., Tan, D.S.W., Chiari, R., Wu, Y.L., Paz-Ares, L. et al. (2017) First-Line Ceritinib versus Platinum-Based Chemotherapy in Advanced ALK-Rearranged Non- Small-Cell Lung Cancer (ASCEND-4): A Randomized, Open-Label, Phase 3 Study. The Lancet, 389, 917-929.
https://doi.org/10.1016/S0140-6736(17)30123-X
https://www.sciencedirect.com/science/article/pii/S014067361730123X
[5]  Timmerman, R., Paulus, R., Galvin, J., Michalski, J., Straube, W., et al. (2010) Stereotactic Body Radiation therapy for Inoperable Early Stage Lung Cancer. JAMA, 303, 1070-1076.
https://doi.org/10.1001/jama.2010.261
https://jamanetwork.com/journals/jama/fullarticle/185547
[6]  Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., et al. (2011) Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non-Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery? International Journal of Radiation Oncology, Biology, Physics, 81, 1352-1358.
https://doi.org/10.1016/j.ijrobp.2009.07.1751
http://www.redjournal.org/article/S0360-3016(09)02787-4/fulltext
[7]  Crabtree, T.D., Denlinger, C.E., Meyers, B.F., Naga, I. E., Zoole, J., et al. (2010) Stereotactic Body Radiation Therapy versus Surgical Resection for Stage I Non-Small Cell Lung Cancer. Journal of Thoracic and Cardiovascular Surgery, 140, 377-386.
https://doi.org/10.1016/j.jtcvs.2009.12.054
http://www.jtcvsonline.org/article/S0022-5223(10)00261-8/abstract
[8]  Chang, J.Y., Senan, S, Paul, M.A., Mehran, R., Louie, A.V., et al. (2015) Stereotactic Ablative Radiotherapy versus Lobectomy for Operable Sage I Non-Small-Cell Lung Cancer: A Pooled Analysis of Two Randomized Trials. The Lancet Oncology, 16, 630-637.
https://doi.org/10.1016/S1470-2045(15)70168-3
https://www.sciencedirect.com/science/article/pii/S1470204515701683
[9]  Grills, I.S., Mangona, V., Welsh, R., Chmielewski, G., McInerney, E. et al. (2009) Outcomes after Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small Cell Lung Cancer. Journal of Clinical Oncology, 28, 928-935.
https://doi.org/10.1200/JCO.2009.25.0928
http://ascopubs.org/doi/abs/10.1200/jco.2009.27.15_suppl.7516
[10]  Scorsetti, M., Alongi, F., Castiglioni, S., Clivio, A., Fogliata, A., et al. (2011) Feasibility and Early Clinical Assessment of Flattening Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments. Radiation Oncology, 6, Article No. 113.
https://doi.org/10.1186/1748-717X-6-113
https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-6-113
[11]  Song, Y., Zhang, P., Obcemea, C., Mueller, B., Burman, C., and Mychalczak, B. (2009) The Development of a Novel Radiation Treatment Modality-Volumetric Modulated Arc Therapy. Conference Proceedings of the IEEE Engineering in Medicine and Biology Society, 2009, 3401-3404.
https://www.ncbi.nlm.nih.gov/pubmed/19963576
[12]  Song, Y., Obcemea, C., Mueller, B., Burman, C., and Mychalczak, B. (2012) A Systematic Approach to Patient Specific QA for Volumetric Modulated Arc Therapy (VMAT). Proceedings of World Congress on Medical Physics and Biomedical Engineering, 39, 1872-1875.
https://doi.org/10.1007/978-3-642-29305-4_493
https://link.springer.com/chapter/10.1007/978-3-642-29305-4_493
[13]  Song, Y., Zhang, P., Obcemea, C., Mueller, B., Burman, C., and Mychalczak, B. (2009) Dosimetric Effects of Gantry Angular Acceleration and Deceleration in Volumetric Modulated Radiation Therapy. Proceedings of World Congress on Medical Physics and Biomedical Engineering, 25, 1046-1050.
https://doi.org/10.1007/978-3-642-03474-9_294
https://link.springer.com/chapter/10.1007/978-3-642-03474-9_294
[14]  Song, Y., Mueller, B., Obcemea, C., and Mychalczak, B. (2011) Feasibility of Implementing Stereotactic Body Radiation Therapy Using a Non-Commercial Volumetric Modulated Arc Therapy Treatment Planning System for Early Stage Lung Cancer. 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Boston, MA, USA, 30 August-3 September 2011, 409-412.
https://doi.org/10.1109/IEMBS.2011.6090130
https://www.ncbi.nlm.nih.gov/pubmed/22254335
[15]  Song, Y., Mueller, B., Obcemea, C., and Mychalczak, B. (2011) Image-Guided Volumetric Modulated Arc Therapy (IG-VMAT) for Prostate Cancer. Proceedings of the 5th European Conference of the International Federation for Medical and Biological Engineering, 37, 223-226.
https://doi.org/10.1007/978-3-642-23508-5_59
https://link.springer.com/chapter/10.1007/978-3-642-23508-5_59

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133